4/A: Teleflex Inc. Executive John Deren Reports Acquisition of Shares and Stock Options
SEC Form 4/A (Amendment to Statement of Changes in Beneficial Ownership)
Teleflex Inc.'s Corporate VP & CAO, John Deren, reports acquiring common stock and stock options, along with an amendment correcting previously reported restricted stock unit award details.
Summary
- On February 27, 2024, John Deren, Corporate VP & CAO of Teleflex Inc., acquired 422 shares of common stock.
- These shares were obtained through a Restricted Stock Unit Award granted under the Teleflex Incorporated 2023 Stock Incentive Plan, vesting fully on the third anniversary of the grant date.
- Deren also acquired 2,957 stock options with an exercise price of $226.04, expiring on February 27, 2034, and exercisable in three equal installments starting February 27, 2025.
- An amendment was filed to correct the number of shares underlying Deren's Restricted Stock Unit Award from 417 to 422 and the amount of securities beneficially owned following reported transactions.
- Following these transactions, Deren directly owns 2,130 shares of common stock and indirectly owns 4.279 shares through a 401(k) trustee.
- He also directly owns 2,957 derivative securities (stock options).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition of shares by an executive is mildly positive, suggesting confidence, but it's not a major event.
Positives
- The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the stock options (2025-2027) implies a multi-year incentive structure for the executive.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the alignment of management's interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock units are standard practice among publicly traded companies, including Teleflex competitors such as Medtronic, Boston Scientific, and Abbott Laboratories.
- The vesting schedules and exercise prices are generally structured to incentivize long-term performance and align executive interests with shareholder value, similar to practices observed in comparable companies.
Stakeholder Impact
- Shareholders may view the executive's stock acquisition as a positive signal, indicating confidence in the company's future prospects.
- The vesting schedule of the stock options aligns the executive's interests with long-term shareholder value.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 02/27/2025 | First vesting date for one-third of the acquired stock options. |
| 02/27/2026 | Second vesting date for one-third of the acquired stock options. |
| 02/27/2027 | Third vesting date for the final one-third of the acquired stock options. |
| 02/27/2034 | Expiration date of the acquired stock options. |
| 06/20/2024 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.